Cohance Lifesciences Revises Q2 and H1 FY27 Earnings Conference Call Timing
Cohance Lifesciences Ltd 路 Intimation 路 04 Nov 2026, 1:07 am
Cohance Lifesciences Revises Q2 and H1 FY27 Earnings Conference Call Timing Cohance Lifesciences Limited has rescheduled its investor and analyst conference call to discuss Q2 and H1 FY27 unaudited financial results. The call is now set for 6th Nov'26 at 6:00 p.m. IST, advanced from the previously scheduled time of 6:30 p.m. IST. The company will announce its financial results earlier on the same day, followed by management discussion and an interactive Q&A session. Primary domestic dial-ins include +91 22 6280 1141 and +91 22 7115 8042, alongside international toll-free options.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
